Skip to main content
SpringerLink
Log in

Reexamination of the Thrombin Hypothesis: What We Have Learned from TIMI 9B and GUSTO IIb

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Harker LA, Hanson SR, Runge MS. Thrombin hypothesis of thrombus generation and vascular lesion formation. Am J Cardiol 1995;75:12B-17B.

    Google Scholar 

  2. Cannon CP, McCabe CH, Henry TD, et al. for the TIMI 5 Investigators. A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial. J Am Coll Cardiol 1994;23:993–1003.

    Google Scholar 

  3. Lee LV for the TIMI 6 Investigators. Initial experience with hirudin and streptokinase in acute myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) 6 trial. Am J Cardiol 1995;75:7–13.

    Google Scholar 

  4. Neuhaus KL, Niederer W, Wagner J, et al. for the ALKKStudy Group. HIT (Hirudin for the Improvement of Thrombolysis): Results of a dose escalation study. Circulation 1993;88:I-292.

    Google Scholar 

  5. Antman EM, for the TIMI 9B Investigators. Hirudin in acute myocardial infarction: Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial. Circulation 1996;94:911–921.

    Google Scholar 

  6. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb Investigators: A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. N Engl J Med 1996;335:775–782.

    Google Scholar 

  7. Weitz JI, Hudoba M, Massel D, Maraganore J, Hirsh J. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. J Clin Invest 1990; 86:385–391.

    Google Scholar 

  8. Zoldhelyi P, Janssens S, Lefevre G, Collen D, Van de Werf F, for the GUSTO-2A Investigators: Effects of heparin and hirudin (CGP 39393) on thrombin generation during thrombolysis for acute myocardial infarction. Circulation 1995;92: I-740.

    Google Scholar 

  9. Rao AK, Sun L, Chesebro JH, et al. for Hirudin in Unstable Angina Trial. Distinct effects of recombinant desulfatohirudin (CGP 39,393) and heparin on plasma levels of fibrinopeptide A and prothrombin fragment F1.2 in unstable angina: A multicenter trial. Thromb Haemost 1995;73:1306 (Abstr).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. TIMI Study Chairman's Office, Brigham and Women's Hospital, 75 Francis Street, Boston, MA, 02115

    Robert P. Giugliano, Elliott M. Antman & Eugene Braunwald

Authors
  1. Robert P. Giugliano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elliott M. Antman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eugene Braunwald
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Giugliano, R.P., Antman, E.M. & Braunwald, E. Reexamination of the Thrombin Hypothesis: What We Have Learned from TIMI 9B and GUSTO IIb. J Thromb Thrombolysis 4, 321–323 (1997). https://doi.org/10.1023/A:1008880829137

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1008880829137

Search

Navigation